I have a new unilateral right‑side headache with tinnitus after a day of diffuse frontal headache and 10 days of zolpidem (sleep aid) use; what is the appropriate management?

Immediate Management: Discontinue Zolpidem and Treat Migraine

You should immediately stop zolpidem and treat this as an acute migraine with unilateral headache progression. The combination of prolonged zolpidem use (10 days), evolving headache pattern (diffuse to unilateral), and new-onset tinnitus raises concern for both medication-related effects and migraine with possible medication overuse.

Primary Clinical Actions

1. Stop Zolpidem Immediately

Zolpidem can cause neuropsychiatric adverse effects including hallucinations, perceptual disturbances, and altered consciousness 1. After 10 days of continuous use, abrupt discontinuation may cause withdrawal symptoms (trouble sleeping, anxiety, agitation) lasting 1-2 days, but these are generally manageable and not life-threatening at this duration 1. The FDA label explicitly warns about abnormal thoughts, behavior changes, and the need to call a healthcare provider if symptoms worsen 1.

Key point: While some sources suggest gradual benzodiazepine/Z-drug tapering 2, 10 days of use is relatively short-term and does not typically require extended tapering protocols. The risk-benefit favors immediate discontinuation given the new neurological symptoms.

2. Treat the Acute Migraine

The progression from diffuse frontal headache to unilateral right-sided headache with tinnitus is consistent with migraine evolution. Start combination therapy immediately 3:

• First-line: Oral NSAID (ibuprofen 400-800 mg or naproxen sodium 550 mg) PLUS a triptan (sumatriptan 50-100 mg, rizatriptan 10 mg, or eletriptan 40 mg) 3, 4
• Alternative if NSAIDs contraindicated: Acetaminophen 1000 mg plus triptan 3
• Timing: Begin treatment as soon as possible after headache onset for maximum efficacy 3, 5

The 2025 American College of Physicians guideline emphasizes that combination therapy (triptan + NSAID or acetaminophen) is more effective than monotherapy for moderate to severe migraine 3.

3. Evaluate the Tinnitus

The unilateral tinnitus requires careful characterization:

Ask specifically:

• Is it pulsatile (rhythmic with heartbeat) or nonpulsatile (continuous ringing/buzzing)? 6
• Does it match the side of the headache?
• Any hearing loss, vertigo, or focal neurological symptoms?

Clinical decision pathway:

• Nonpulsatile tinnitus + unilateral + no hearing loss + no neurological deficits: This is likely primary/idiopathic tinnitus or migraine-associated tinnitus. No imaging is indicated 6. The 2023 ACR guidelines and AAO-HNS make strong recommendations against imaging for subjective, nonpulsatile tinnitus without focal abnormalities 6, 7, 6.

• If pulsatile tinnitus: Requires otoscopic examination first, then temporal bone CT as first-line imaging to evaluate for vascular abnormalities 7, 6

• If unilateral tinnitus WITH asymmetric hearing loss or neurological deficits: Consider MRI brain with internal auditory canal protocol to exclude retrocochlear lesion (vestibular schwannoma) 6

Addressing Medication Overuse Risk

After 10 days of zolpidem, you're not yet at risk for medication overuse headache (MOH), which requires ≥3 months of regular use 3. However, counsel the patient now about MOH prevention:

• NSAIDs: limit to <15 days/month 3
• Triptans: limit to <10 days/month 3
• Never use opioids or butalbital for migraine 3, 4

Sleep Management Without Zolpidem

Since zolpidem was used for sleep, address insomnia appropriately:

• Non-pharmacologic first: Sleep hygiene, regular sleep schedule, avoid caffeine after noon, cognitive behavioral therapy for insomnia (CBT-I) 8, 2
• If pharmacotherapy needed: Consider melatonin 2-3 mg at bedtime (safer profile than Z-drugs) 9, 10, 2 or low-dose trazodone 11
• Avoid: Restarting zolpidem or other Z-drugs given the neuropsychiatric symptoms 11, 12

Red Flags Requiring Urgent Evaluation

Seek immediate evaluation if any of these develop:

• Sudden severe "thunderclap" headache
• Fever, neck stiffness, altered mental status
• New focal neurological deficits (weakness, vision changes, speech difficulty)
• Pulsatile tinnitus with objective findings on examination
• Progressive worsening despite treatment

Follow-Up Timeline

• 24-48 hours: Reassess headache response to acute treatment
• 1 week: If headaches persist or recur frequently (>4 days/month), consider migraine preventive therapy (topiramate, valproate, propranolol, or CGRP monoclonal antibodies) 3, 4
• 2-4 weeks: If tinnitus persists and is bothersome, refer to audiology for comprehensive audiological evaluation 13

The most critical action is stopping zolpidem now and treating the acute migraine with combination therapy. The tinnitus will likely improve as the headache resolves, but requires monitoring and potential audiological evaluation if persistent beyond 2-4 weeks.